Results 81 to 90 of about 691 (136)

Frequency and Profiles of Drug Combinations Constituting the Triple Whammy in Japan: An Analysis of a Patient Estimation Database. [PDF]

Pharmacy (Basel)
Maese M, Ito N, Shiokawa H, Kondo S, Okamoto Y, Iwata H, Urushibata S, Yamaura K.   +7 more
europepmc   +1 more source

Safety, tolerability, and efficacy of azilsartan medoxomil with or without chlorthalidone during and after 8 months of treatment for hypertension. [PDF]

J Clin Hypertens (Greenwich), 2015
Kipnes MS, Handley A, Lloyd E, Barger B, Roberts A.   +4 more
europepmc   +1 more source

Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study. [PDF]

Clin Exp Hypertens, 2016
Handley A, Lloyd E, Roberts A, Barger B.
europepmc   +1 more source

Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes. [PDF]

J Hypertens, 2016
White WB, Cuadra RH, Lloyd E, Bakris GL, Kupfer S.   +4 more
europepmc   +1 more source

Comparative efficacy and safety of dual-combination vs. triple-combination antihypertensive therapies in hypertensive patients: an updated meta-analysis of randomized controlled trials. [PDF]

Front Pharmacol
Gong Z, Huang L, Long X, Zhang Y.
europepmc   +1 more source

The Impact of Azilsartan Medoxomil Treatment (Capsule Formulation) at Doses Ranging From 10 to 80 mg: Significant, Rapid Reductions in Clinic Diastolic and Systolic Blood Pressure. [PDF]

J Clin Hypertens (Greenwich), 2017
Perez A, Cao C.
europepmc   +1 more source

Telmisartan Repurposing Targets Novel Biomarkers for Precision Colorectal Cancer Therapy. [PDF]

Pharmaceutics
Hunachagi S, Alqudihi HH, AbdulAzeez S, Borgio JF, Almohazey D.   +4 more
europepmc   +1 more source

Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry. [PDF]

J Clin Hypertens (Greenwich), 2015
Schmieder RE, Potthoff SA, Bramlage P, Baumgart P, Mahfoud F, Buhck H, Ouarrak T, Ehmen M, Senges J, Gitt AK, EARLY Registry Group.   +10 more
europepmc   +1 more source

New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil. [PDF]

Integr Blood Press Control, 2012
Volpe M, Savoia C.
europepmc   +1 more source

Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study. [PDF]

J Clin Hypertens (Greenwich), 2012
Sica D, Bakris GL, White WB, Weber MA, Cushman WC, Huang P, Roberts A, Kupfer S.   +7 more
europepmc   +1 more source